Erlonat 150 Mg Tablet 30’s

What Is Erlonat 150mg Tablet?

Erlonat 150mg Tablet contains Erlotinib, an epidermal growth factor receptor (EGFR) inhibitor. It is primarily used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlotinib works by blocking the EGFR, a protein that promotes the growth and spread of cancer cells, thereby slowing down the growth of tumors.

Benefits:

• Effective against NSCLC: It helps in treating advanced or metastatic non-small cell lung cancer.
• Pancreatic cancer treatment: Used alongside other chemotherapy drugs for pancreatic cancer.
• Targeted therapy: Specifically targets cancer cells with fewer effects on healthy cells, which may lead to a more tolerable treatment compared to traditional chemotherapy.
• Oral administration: Taken as a tablet, offering convenience compared to intravenous chemotherapy.

Side Effects:

• Common side effects:
  • Rash or skin irritation (acne-like rash)
  • Diarrhea
  • Nausea or loss of appetite
  • Fatigue
  • Cough or shortness of breath
• Serious side effects:
  • Liver problems (yellowing of the skin or eyes, dark urine, abdominal pain)
  • Severe lung issues (difficulty breathing, coughing, or chest pain)
  • Eye irritation or vision problems
  • Severe skin reactions or blisters

If you experience severe side effects, seek immediate medical attention.

FAQs:

1. How should I take Erlonat 150mg Tablet?
   • Take Erlonat exactly as prescribed, typically once a day on an empty stomach, at least 1 hour before or 2 hours after a meal. Swallow the tablet whole with water.
2. Can I take Erlonat with other medications?
   • Some medications may interact with Erlonat. Always inform your doctor about any other medicines or supplements you’re taking.
3. Can I use Erlonat if I’m pregnant or breastfeeding?
   • No, Erlonat should not be used during pregnancy or breastfeeding as it can harm the fetus or infant. Discuss alternative treatments with your doctor.
4. How long will I need to take Erlonat?
   • The duration of treatment depends on the type of cancer, its response to the medication, and other factors. Your doctor will adjust the treatment plan based on your progress.